• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索含有联苯核心的 P2Y 受体拮抗剂的替代支架。

Exploration of Alternative Scaffolds for P2Y Receptor Antagonists Containing a Biaryl Core.

机构信息

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.

Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina 27709, United States.

出版信息

J Med Chem. 2020 Sep 10;63(17):9563-9589. doi: 10.1021/acs.jmedchem.0c00745. Epub 2020 Aug 6.

DOI:10.1021/acs.jmedchem.0c00745
PMID:32787142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040948/
Abstract

Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y receptor (P2YR) antagonists were synthesized, and affinity was measured in P2YR-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central -benzoic acid core () provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2YR region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist , e.g., quinuclidine (MRS4608, IC ≈ 20 nM at hP2YR/mP2YR), or of triazole , preserved affinity. Potent antagonists , , , and (10 mg/kg) protected in an ovalbumin/ mouse asthma model, and PEG conjugate reduced chronic pain. Thus, we expanded P2YR antagonist structure-activity relationship, introducing diverse physical-chemical properties.

摘要

各种杂芳基和双环脂肪族 P2Y 受体(P2YR)两性离子拮抗剂类似物被合成,并通过流式细胞术在表达 P2YR 的中国仓鼠卵巢细胞中测量亲和力。鉴于该系列的低水溶性,合成了具有中等亲和力的远端结合哌啶-4-基部分的各种聚乙二醇衍生物。先前鉴定的连接到中央 -苯甲酸核的 1,2,3-三唑的旋转提供了中等亲和力,但不是吲哚和苯并咪唑取代芳基-三唑。同源建模预测 P2YR 区域为一个深的、空间受限的疏水性口袋,向外指向的哌啶部分最灵活。萘拮抗剂 的双环取代哌啶环衍生物,例如喹诺啶 (MRS4608,在 hP2YR/mP2YR 上的 IC ≈ 20 nM),或三唑 ,保留了亲和力。有效拮抗剂 、 、 、 (10 mg/kg)在卵清蛋白/小鼠哮喘模型中具有保护作用,PEG 缀合物 减轻了慢性疼痛。因此,我们扩展了 P2YR 拮抗剂的结构-活性关系,引入了各种物理化学性质。

相似文献

1
Exploration of Alternative Scaffolds for P2Y Receptor Antagonists Containing a Biaryl Core.探索含有联苯核心的 P2Y 受体拮抗剂的替代支架。
J Med Chem. 2020 Sep 10;63(17):9563-9589. doi: 10.1021/acs.jmedchem.0c00745. Epub 2020 Aug 6.
2
Structure-Activity Relationship of Heterocyclic P2Y Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres.杂环 P2Y 受体拮抗剂的构效关系:用哌啶生物等排体去除两性离子特征。
J Med Chem. 2021 Apr 22;64(8):5099-5122. doi: 10.1021/acs.jmedchem.1c00164. Epub 2021 Mar 31.
3
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists.基于结构的3-(4-芳基-1H-1,2,3-三唑-1-基)-联苯衍生物作为P2Y14受体拮抗剂的设计
J Med Chem. 2016 Jul 14;59(13):6149-68. doi: 10.1021/acs.jmedchem.6b00044. Epub 2016 Jun 22.
4
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y Receptor.基于结构的 P2Y 受体杂环拮抗剂的修饰。
J Med Chem. 2018 Jun 14;61(11):4860-4882. doi: 10.1021/acs.jmedchem.8b00168. Epub 2018 May 16.
5
Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes.探索基于结构设计P2Y14受体拮抗剂分子探针的2-萘甲酸模板。
ACS Chem Biol. 2014 Dec 19;9(12):2833-42. doi: 10.1021/cb500614p. Epub 2014 Oct 20.
6
Recent progress on the discovery of P2Y receptor antagonists.新型 P2Y 受体拮抗剂的研究进展。
Eur J Med Chem. 2019 Aug 1;175:34-39. doi: 10.1016/j.ejmech.2019.04.068. Epub 2019 Apr 29.
7
Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y receptor antagonists.设计、合成及 3-酰胺苯甲酸衍生物的抗炎活性评价作为新型 P2Y 受体拮抗剂。
Eur J Med Chem. 2019 Nov 1;181:111564. doi: 10.1016/j.ejmech.2019.111564. Epub 2019 Jul 26.
8
Discovery of a series of novel 3-sulfonamido benzoic acid derivatives as promising P2YR antagonists for acute lung injury.发现一系列新型3-磺酰胺基苯甲酸衍生物作为急性肺损伤有前景的P2YR拮抗剂。
Eur J Med Chem. 2025 Jun 5;290:117588. doi: 10.1016/j.ejmech.2025.117588. Epub 2025 Apr 1.
9
Discovery of N-Substituted Acetamide Derivatives as Promising P2YR Antagonists Using Molecular Hybridization Based on Crystallographic Overlay.基于晶体叠合的分子杂交发现 N-取代乙酰胺衍生物作为有前景的 P2YR 拮抗剂。
J Med Chem. 2024 Jun 27;67(12):10233-10247. doi: 10.1021/acs.jmedchem.4c00555. Epub 2024 Jun 14.
10
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YR Antagonist.高亲和力萘基 P2YR 拮抗剂的桥连哌啶类似物。
J Med Chem. 2022 Feb 24;65(4):3434-3459. doi: 10.1021/acs.jmedchem.1c01964. Epub 2022 Feb 3.

引用本文的文献

1
Design, Synthesis and Anti-Inflammation Evaluation of -Acyl Tryptophan Derivatives as Promising P2YR Antagonists Against Lipopolysaccharide-Induced Acute Lung Injury.作为有望对抗脂多糖诱导的急性肺损伤的P2YR拮抗剂的α-酰基色氨酸衍生物的设计、合成及抗炎评价
Drug Des Devel Ther. 2025 Aug 20;19:7215-7245. doi: 10.2147/DDDT.S497291. eCollection 2025.
2
Drug-like Antagonists of P2Y Receptor Subtypes: An Update.P2Y 受体亚型的类药拮抗剂:最新进展
J Med Chem. 2025 May 8;68(9):9057-9083. doi: 10.1021/acs.jmedchem.5c00249. Epub 2025 Apr 27.
3
Chimeras Derived from a P2Y Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation.源自P2Y受体拮抗剂和UDP-糖激动剂的嵌合体用于炎症的潜在治疗
ACS Pharmacol Transl Sci. 2024 Sep 26;7(10):3255-3278. doi: 10.1021/acsptsci.4c00489. eCollection 2024 Oct 11.
4
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics.对嘌呤能P2受体在疾病中的潜在作用的全面见解:涉及的信号通路及潜在治疗方法。
J Adv Res. 2025 Mar;69:427-448. doi: 10.1016/j.jare.2024.03.027. Epub 2024 Mar 31.
5
Pharmacological characterization of P2Y receptor subtypes - an update.P2Y 受体亚型的药理学特征——更新。
Purinergic Signal. 2024 Apr;20(2):99-108. doi: 10.1007/s11302-023-09963-w. Epub 2023 Sep 12.
6
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y Receptor Antagonists.作为 P2Y 受体拮抗剂的 4-苯基-2-萘甲酸衍生物中环大小的变化。
J Med Chem. 2023 Jul 13;66(13):9076-9094. doi: 10.1021/acs.jmedchem.3c00664. Epub 2023 Jun 29.
7
Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targets.作为肥胖和 2 型糖尿病靶点的脂肪细胞嘌呤能受体被尿嘧啶核苷酸激活。
Curr Opin Pharmacol. 2022 Apr;63:102190. doi: 10.1016/j.coph.2022.102190. Epub 2022 Feb 26.
8
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YR Antagonist.高亲和力萘基 P2YR 拮抗剂的桥连哌啶类似物。
J Med Chem. 2022 Feb 24;65(4):3434-3459. doi: 10.1021/acs.jmedchem.1c01964. Epub 2022 Feb 3.
9
Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization.涉及配体识别和二聚化的嘌呤能 GPCR 跨膜残基。
Methods Cell Biol. 2021;166:133-159. doi: 10.1016/bs.mcb.2021.06.001. Epub 2021 Jul 12.
10
Purinergic Signaling in Liver Pathophysiology.嘌呤能信号在肝脏病理生理学中的作用。
Front Endocrinol (Lausanne). 2021 Aug 11;12:718429. doi: 10.3389/fendo.2021.718429. eCollection 2021.

本文引用的文献

1
P2Y Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.P2Y受体拮抗剂可逆转小鼠模型中的慢性神经性疼痛。
ACS Med Chem Lett. 2020 Apr 30;11(6):1281-1286. doi: 10.1021/acsmedchemlett.0c00115. eCollection 2020 Jun 11.
2
Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice.促炎型 P2Y14 受体抑制可预防小鼠缺血性急性肾损伤。
J Clin Invest. 2020 Jul 1;130(7):3734-3749. doi: 10.1172/JCI134791.
3
Targeting acidity in cancer and diabetes.靶向癌症和糖尿病的酸性环境。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):273-280. doi: 10.1016/j.bbcan.2019.01.003. Epub 2019 Jan 30.
4
Extracellular nucleotides and nucleosides as signalling molecules.细胞外核苷酸和核苷作为信号分子。
Immunol Lett. 2019 Jan;205:16-24. doi: 10.1016/j.imlet.2018.11.006. Epub 2018 Nov 12.
5
Naphthalene, a versatile platform in medicinal chemistry: Sky-high perspective.萘,药物化学中的多功能平台:高瞻远瞩的视角。
Eur J Med Chem. 2019 Jan 1;161:252-276. doi: 10.1016/j.ejmech.2018.10.018. Epub 2018 Oct 15.
6
Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines.通过增加碳原子降低亲脂性:吗啡啉和哌嗪的单碳桥。
J Med Chem. 2018 Oct 11;61(19):8934-8943. doi: 10.1021/acs.jmedchem.8b01148. Epub 2018 Sep 20.
7
Cubanes in Medicinal Chemistry.药用化学中的笼状化合物
J Med Chem. 2019 Feb 14;62(3):1078-1095. doi: 10.1021/acs.jmedchem.8b00888. Epub 2018 Sep 6.
8
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y Receptor.基于结构的 P2Y 受体杂环拮抗剂的修饰。
J Med Chem. 2018 Jun 14;61(11):4860-4882. doi: 10.1021/acs.jmedchem.8b00168. Epub 2018 May 16.
9
Empowering human cardiac progenitor cells by P2Y nucleotide receptor overexpression.过表达 P2Y 核苷酸受体可增强人心肌祖细胞功能。
J Physiol. 2017 Dec 1;595(23):7135-7148. doi: 10.1113/JP274980. Epub 2017 Nov 9.
10
Polypharmacology of conformationally locked methanocarba nucleosides.构象锁定的甲桥核苷的多药理学。
Drug Discov Today. 2017 Dec;22(12):1782-1791. doi: 10.1016/j.drudis.2017.07.013. Epub 2017 Aug 3.